You have 9 free searches left this month | for more free features.

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

TransThera Sciences (Nanjing), Inc. (3)

Collaborator

Intervention

tt-00420 (3)

combination product: atezolizumab (1)

combination product: nab-paclitaxel (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

tt-00420

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation Trial in United States (TT-00420)

Recruiting

Cholangiocarcinoma
+4 more

TT-00420

Anchorage, Alaska
+16 more

Jan 3, 2023

Advanced Solid Tumor, Cholangiocarcinoma, Biliary Tract Cancer Trial in Beijing, Jinan, Shanghai (TT-00420, Combination Product:

Not yet recruiting

Advanced Solid Tumor
+10 more

TT-00420
+2 more

Beijing, China
+3 more

Feb 14, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer Trial in Houston, Beijing (TT-00420)

Active, not recruiting

Advanced Solid Tumors
Triple Negative Breast Cancer

TT-00420

Houston, Texas
+1 more

Oct 25, 2021